Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : XOMA. Bull or Bear? -- Ignore unavailable to you. Want to Upgrade?

To: Dan O who wrote (7093)	9/1/1998 10:43:00 AM
From: charles moore	Respond to of 17367

Dan: I started buying at 2 3/4. Got some at 2 1/4. Average price at this Juncture is about 2 1/2 less commissions. I have been watching it for a while. Its not that I am real good at picking the bottom but the fact is that I was looking at other stocks and had just got around to XOMA with the cash when it was at 2 3/4. Xoma is not one of my bigger holdings at this point.I first saw the Stock recommended by "Taipan" advisory newsletter.They recommended a "Buy" on anything under $4.50,however, it is one of their recommendations that they do list in the "Speculative" category. They seem to base their recommendation on Neuprex and feel if this goes so goes XOMA. Yes, I believe a buyout in which Insiders "lined" their pockets at the expense of Shareholders would result in a Lawsuit.Here again unless the "Suit" is real rewarding it is the Lawyers who get the bulk of the settlement.Taipan and others recommending a buy below $4.50 would set off "bells" if a low buyout was initiated.The Company needs to clarify and assure the shareholders.Dont know about the Kenzie report. I gave my opinion on the reasons with what info I have. A buyout doesnt necessarily mean a low figure but then that is relative depending on ones Entry point. Charles